The real-world efficacy of botulinum toxin type a (botox(R)) for the prophylaxis of headaches in adult patients with chronic migraine in australian clinical practice: a retrospective chart review
Conclusions
In an Australian clinical practice review, almost three-quarters of CM patients obtained a meaningful reduction in headache days following two BOTOX treatments, fulfilling PBS continuation criterion. Additionally, the use of acute migraine medicines, including opioids, was reduced.
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: Stark, C., Stark, R., Limberg, N., Andrews, C., Rodrigues, J., Cordato, D., Schwartz, R., Michelle, F. J., Jonathan, T. Tags: Abstracts Source Type: research
More News: Amitriptyline | Botox | Brain | Headache | Inderal | Migraine | Neurology | Neurosurgery | Psychiatry | Topamax